• Je něco špatně v tomto záznamu ?

Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions [Protein tau-mediated effects on rat hippocampal choline transporters CHT1 and tau-amyloid beta interactions]

Z. Kristofikova, D. Ripova, K. Hegnerová, J. Sirova, J. Homola,

. 2013 ; 38 (9) : 1949-1959.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14050935

Grantová podpora
NT11225 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

It is suggested that intracellular tau protein (τ), when released extracellularly upon neuron degeneration, could evoke direct toxic effects on the cholinergic neurotransmitter system through muscarinic receptors and thus contribute to the pathogenesis of Alzheimer's disease. In this study, we evaluated the in vitro effects of six naturally occurring monomeric τ isoforms on rat hippocampal synaptosomal choline transporters CHT1 (large transmembrane proteins associated with high-affinity choline transport and vulnerable to actions of amyloid β peptides (Aβ) applied in vitro or in vivo). Some τ isoforms at nM concentrations inhibited choline transport in a dose- and time-dependent saturable manner (352 = 441 > 410 = 383 > 381 = 412) and effects were associated with changes in the Michaelis constant rather than in maximal velocity. Moreover, the actions of τ 352/441 were not influenced by previous depolarisation of synaptosomes or by previous depletion of membrane cholesterol. Specific binding of [3H]hemicholinium-3 was not significantly altered by τ 352/441 at higher nM concentrations. Results of in vitro tests on CHT1 transporters from cholesterol-depleted synaptosomes supported interactions between Aβ 1-40 and τ 352. In addition, we developed surface plasmon resonance biosensors to monitor complexes of Aβ 1-42 and τ 352 using a sandwich detection format. It seems, therefore, that protein τ, similar to Aβ peptides, can contribute to the pathogenesis of Alzheimer's disease through its actions on CHT1 transporters. However, the interaction mechanisms are quite different (τ probably exerts its effects through direct interactions of microtubule binding repeats with extracellular portions of the CHT1 protein without influencing the choline recognition site, Aβ rather through lipid rafts in the surrounding membranes). An N-terminal insert of τ is not necessary but the N-terminal projection domain plays a role. The developed biosensor will be used to detect Aβ-τ complexes in cerebrospinal fluid in order to evaluate them as prospective biomarkers of Alzheimer's disease.

Protein tau-mediated effects on rat hippocampal choline transporters CHT1 and tau-amyloid beta interactions

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14050935
003      
CZ-PrNML
005      
20150109135625.0
007      
ta
008      
140401s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11064-013-1101-5 $2 doi
035    __
$a (PubMed)23824558
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kristofikova, Zdena $u Alzheimer Disease Centre, Prague Psychiatric Centre, Prague, Czech Republic
245    10
$a Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions / $c Z. Kristofikova, D. Ripova, K. Hegnerová, J. Sirova, J. Homola,
246    31
$a Protein tau-mediated effects on rat hippocampal choline transporters CHT1 and tau-amyloid beta interactions
520    9_
$a It is suggested that intracellular tau protein (τ), when released extracellularly upon neuron degeneration, could evoke direct toxic effects on the cholinergic neurotransmitter system through muscarinic receptors and thus contribute to the pathogenesis of Alzheimer's disease. In this study, we evaluated the in vitro effects of six naturally occurring monomeric τ isoforms on rat hippocampal synaptosomal choline transporters CHT1 (large transmembrane proteins associated with high-affinity choline transport and vulnerable to actions of amyloid β peptides (Aβ) applied in vitro or in vivo). Some τ isoforms at nM concentrations inhibited choline transport in a dose- and time-dependent saturable manner (352 = 441 > 410 = 383 > 381 = 412) and effects were associated with changes in the Michaelis constant rather than in maximal velocity. Moreover, the actions of τ 352/441 were not influenced by previous depolarisation of synaptosomes or by previous depletion of membrane cholesterol. Specific binding of [3H]hemicholinium-3 was not significantly altered by τ 352/441 at higher nM concentrations. Results of in vitro tests on CHT1 transporters from cholesterol-depleted synaptosomes supported interactions between Aβ 1-40 and τ 352. In addition, we developed surface plasmon resonance biosensors to monitor complexes of Aβ 1-42 and τ 352 using a sandwich detection format. It seems, therefore, that protein τ, similar to Aβ peptides, can contribute to the pathogenesis of Alzheimer's disease through its actions on CHT1 transporters. However, the interaction mechanisms are quite different (τ probably exerts its effects through direct interactions of microtubule binding repeats with extracellular portions of the CHT1 protein without influencing the choline recognition site, Aβ rather through lipid rafts in the surrounding membranes). An N-terminal insert of τ is not necessary but the N-terminal projection domain plays a role. The developed biosensor will be used to detect Aβ-τ complexes in cerebrospinal fluid in order to evaluate them as prospective biomarkers of Alzheimer's disease.
650    _2
$a amyloidní beta-protein $x metabolismus $7 D016229
650    _2
$a zvířata $7 D000818
650    _2
$a proteiny přenášející kationty $x metabolismus $7 D027682
650    _2
$a hipokampus $x metabolismus $7 D006624
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a povrchová plasmonová rezonance $7 D020349
650    _2
$a proteiny tau $x metabolismus $7 D016875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ripova, Daniela $u Alzheimer Disease Centre, Prague Psychiatric Centre, Prague, Czech Republic
700    1_
$a Hegnerová, Katerina $u Institute of Photonics and Electronics, Academy of Sciences, Prague, Czech Republic
700    1_
$a Sirova, Jana $u Alzheimer Disease Centre, Prague Psychiatric Centre, Prague, Czech Republic
700    1_
$a Homola, Jiri $u Institute of Photonics and Electronics, Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00003484 $t Neurochemical research $x 1573-6903 $g Roč. 38, č. 9 (2013), s. 1949-1959
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23824558 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140401 $b ABA008
991    __
$a 20150109135803 $b ABA008
999    __
$a ok $b bmc $g 1018071 $s 849515
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 38 $c 9 $d 1949-1959 $i 1573-6903 $m Neurochemical research $n Neurochem Res $x MED00003484
GRA    __
$a NT11225 $p MZ0
LZP    __
$a Pubmed-20140401

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...